While Costco and Walmart have delivered strong returns, their valuations are stretched with forward P/E ratios of 48.7 and 43.4 respectively, and low dividend yields of 0.5% and 0.8%. Kimberly-Clark offers a compelling alternative with a 5.3% dividend yield, 54 consecutive years of dividend increases, and a cheap valuation at 12.8x forward earnings. The company's strategic exit from low-margin private-label diapers and planned acquisition of Kenvue (adding brands like Band-Aid and Tylenol) position it for margin expansion and dividend growth.

Three Dividend Kings—Altria, Universal Corporation, and Kimberly-Clark—currently offer the highest dividend yields among elite dividend stocks that have increased dividends for 50+ consecutive years. Altria yields 6.3% but faces declining cigarette demand in North America. Universal yields 6.1% as a global tobacco supplier with stronger international demand. Kimberly-Clark yields 5.2% and is pursuing a growth strategy through its acquisition of Kenvue, though this carries integration risks. All three are considered riskier investments suitable primarily for aggressive investors.

Johnson & Johnson is highlighted as an exceptional dividend stock for retirees, boasting a 63-year dividend-increase streak as a Dividend King. The diversified healthcare company combines pharmaceutical and medical device businesses, with an AAA credit rating ensuring dividend stability. However, its 2.2% yield, while double the S&P 500's 1.1%, falls short of the 4% target many dividend investors seek.

A major M&A week sees Sysco acquiring Restaurant Depot for $26 billion and McCormick merging with Unilever's food division for $44 billion, while Eli Lilly acquires Centessa Pharmaceuticals for $7.8 billion. The podcast discusses the track record of consumer brand mergers (mostly unsuccessful) and analyzes Whirlpool as a dividend investment amid housing market headwinds.

Nike, Kimberly-Clark, and Conagra Brands have all declined significantly over the past five years and are trading at valuations not seen in over a decade. While these stocks present potential buying opportunities at low valuations, each faces substantial headwinds: Nike struggles with competition and margin pressure, Kimberly-Clark faces uncertainty from its planned Kenvue acquisition, and Conagra battles weak growth and concerns about dividend sustainability.

Johnson & Johnson demonstrates resilience during market downturns, with shares falling less than 2% while the S&P 500 dropped over 7%. The healthcare giant maintains strong fundamentals including 63 consecutive years of dividend increases, $94.2 billion in 2025 revenue (up 6%), and 51 drug approvals last year. However, the stock faces headwinds from tens of thousands of talc-related lawsuits and Medicare drug price negotiations under the Inflation Reduction Act.

The article highlights three Dividend Kings as strong buy opportunities in March 2026: Genuine Parts (GPC), which recently pulled back after disappointing earnings but offers a 3.7% dividend yield and a potential split-up catalyst; Kimberly-Clark (KMB), which is acquiring Kenvue and expects $2 billion in cost synergies; and Target (TGT), which has rallied significantly but still offers upside potential with a 3.9% dividend yield and strong earnings growth forecasts.

Activist investor Starboard Value LP acquired a 5.19 million share stake in engineering and construction firm Fluor Corporation worth $205.73 million, representing 3.9% of its reportable assets. The investment reflects confidence in Fluor's ability to capitalize on accelerating industrial and energy infrastructure investment cycles, though investors will monitor whether the company can convert its growing project backlog into steady, profitable earnings without cost overruns.

Activist investor Starboard Value LP has acquired a significant 4.55% stake in Clearwater Analytics, purchasing 9,959,031 shares valued at $240.21 million. The investment in the cloud-based investment accounting software provider reflects confidence in its structural competitive advantages, including high switching costs and regulatory requirements that create sticky recurring revenue. However, the stock has underperformed the market by 26.7 percentage points over the past year.

Conagra Brands and Kimberly-Clark are presented as bargain investment opportunities despite significant stock declines over the past three years. Both companies have been pressured by inflation, leading to lower valuations and higher dividend yields. Conagra trades at 11x forward earnings with a 7.3% dividend yield, while Kimberly-Clark trades at 15x earnings with a 4.5% yield and a 54-year dividend increase streak. Kimberly-Clark's pending Kenvue acquisition is expected to drive future growth.

The article highlights three dividend stocks that have declined 20% or more from their 52-week highs and may present buying opportunities for long-term investors. Best Buy faces headwinds from slowing consumer spending and tariff uncertainty but offers a sustainable 5.9% dividend yield. Kimberly-Clark's planned $48.7 billion acquisition of Kenvue could drive future earnings growth and dividend increases despite initial market skepticism. Kraft Heinz, which paused its planned split, trades at attractive valuations with a 6.6% dividend yield and potential for upside if fundamentals improve.

Kimberly-Clark (KMB) is highlighted as an attractive dividend stock in 2026, offering a 4.7% yield and trading at a discounted 14.6x forward P/E ratio compared to sector peers. The company is a Dividend King with 54 consecutive years of dividend increases. While the consumer staples sector has surged 14.9% year-to-date, Kimberly-Clark remains undervalued relative to competitors like Walmart and Coca-Cola. The stock is positioned to benefit from its pending Kenvue acquisition, which is expected to deliver synergies and earnings growth.